Bladder Cancer Treatment Drugs Market Report

China Bladder Cancer Treatment Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 14, 2023
  • PAGES：142
  • REPORT CODE：GMM1853512
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumor, which even spread in the surrounding tissues or muscles.

    The increase in prevalence of bladder cancer, advanced health care services, technological advancements, drug innovations with regard to the treatment of this cancer for ex launch of EOquin, and government initiatives could contribute to the growth of the bladder cancer treatment drugs market. Majority of bladder cancer patients are over the age of 60. Rise in the geriatric population is anticipated to drive the market growth. Additionally, growing awareness about bladder diseases, therapies available in the market, and increasing health care expenditure are significantly contributing toward the growth of the global bladder cancer treatment drugs market. However, rise in number of patent expirations, increase in use of generic drugs, and asymptomatic nature of the disease are some major factors that could hamper the growth of the market.North America dominates the bladder cancer treatment drugs market followed by Europe. Rise in bladder cancer cases, availability of advanced health care solutions, developed health care infrastructure, and growing concern regarding the disease in these regions are key factors attributed to the significant market share. However, rapidly increasing prevalence of bladder cancer in the Asia Pacific region, in which India being the major country having large number of patients suffering from this disease, is expected to experience a high growth rate in the bladder cancer treatment drugs market over the forecast period. Further, increasing awareness about cancer diagnosis, growing demand for improved bladder cancer treatments and therapies, developing health care infrastructure, and rising health care expenditure in the region can drive the market growth.

    This report elaborates on the current development of the Bladder Cancer Treatment Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis International

    • Bristol-Myers Squibb

    • Sanofi

    • Celgene Corporation

    • Eli Lilly

    • Hoffmann-La Roche

    • GlaxoSmithKline

    • AstraZeneca

    By Type:

    • Non-Muscle-Invasive Bladder Cancer

    • Muscle-Invasive Bladder Cancer

    By Application:

    • High-Grade Tumors

    • Low-Grade Tumors

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bladder Cancer Treatment Drugs Market Overview 2018-2029

    • 1.1 China Bladder Cancer Treatment Drugs Industry Development Overview

    • 1.2 China Bladder Cancer Treatment Drugs Industry Development History

    • 1.3 China Bladder Cancer Treatment Drugs Industry Market Size (2018-2029)

    • 1.4 China Bladder Cancer Treatment Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Bladder Cancer Treatment Drugs Production Volume, Production Value and Growth Rate of Non-Muscle-Invasive Bladder Cancer (2018-2029)

      • 1.4.2 China Bladder Cancer Treatment Drugs Production Volume, Production Value and Growth Rate of Muscle-Invasive Bladder Cancer (2018-2029)

    • 1.5 China Bladder Cancer Treatment Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Bladder Cancer Treatment Drugs Sales Volume, Sales Value and Growth Rate of High-Grade Tumors (2018-2029)

      • 1.5.2 China Bladder Cancer Treatment Drugs Sales Volume, Sales Value and Growth Rate of Low-Grade Tumors (2018-2029)

    • 1.6 China Bladder Cancer Treatment Drugs Market Analysis by Region

      • 1.6.1 North China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bladder Cancer Treatment Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bladder Cancer Treatment Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bladder Cancer Treatment Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Bladder Cancer Treatment Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bladder Cancer Treatment Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bladder Cancer Treatment Drugs Industry Development

    Chapter 3 Bladder Cancer Treatment DrugsIndustry Chain Analysis

    • 3.1 Bladder Cancer Treatment Drugs Industry Chain

    • 3.2 Bladder Cancer Treatment Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bladder Cancer Treatment Drugs Market

    • 3.3 Bladder Cancer Treatment Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bladder Cancer Treatment Drugs Market

    Chapter 4 China Bladder Cancer Treatment Drugs Market, by Type

    • 4.1 China Bladder Cancer Treatment Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bladder Cancer Treatment Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bladder Cancer Treatment Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Bladder Cancer Treatment Drugs Production Volume and Growth Rate of Non-Muscle-Invasive Bladder Cancer

      • 4.5.2 China Bladder Cancer Treatment Drugs Production Volume and Growth Rate of Muscle-Invasive Bladder Cancer

    Chapter 5 China Bladder Cancer Treatment Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bladder Cancer Treatment Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bladder Cancer Treatment Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Bladder Cancer Treatment Drugs Market Size and Growth Rate of High-Grade Tumors

      • 5.5.2 China Bladder Cancer Treatment Drugs Market Size and Growth Rate of Low-Grade Tumors

    Chapter 6 China Bladder Cancer Treatment Drugs Market, by Region

    • 6.1 China Bladder Cancer Treatment Drugs Production Volume and Production Value, by Region

    • 6.2 China Bladder Cancer Treatment Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Bladder Cancer Treatment Drugs Market Analysis

    • 7.1 North China Bladder Cancer Treatment Drugs Market, by Type

    • 7.2 North China Bladder Cancer Treatment Drugs Market, by Application

    Chapter 8 Central China Bladder Cancer Treatment Drugs Market Analysis

    • 8.1 Central China Bladder Cancer Treatment Drugs Market, by Type

    • 8.2 Central China Bladder Cancer Treatment Drugs Market, by Application

    Chapter 9 South China Bladder Cancer Treatment Drugs Market Analysis

    • 9.1 South China Bladder Cancer Treatment Drugs Market, by Type

    • 9.2 South China Bladder Cancer Treatment Drugs Market, by Application

    Chapter 10 East China Bladder Cancer Treatment Drugs Market Analysis

    • 10.1 East China Bladder Cancer Treatment Drugs Market, by Type

    • 10.2 East China Bladder Cancer Treatment Drugs Market, by Application

    Chapter 11 Northeast China Bladder Cancer Treatment Drugs Market Analysis

    • 11.1 Northeast China Bladder Cancer Treatment Drugs Market, by Type

    • 11.2 Northeast China Bladder Cancer Treatment Drugs Market, by Application

    Chapter 12 Southwest China Bladder Cancer Treatment Drugs Market Analysis

    • 12.1 Southwest China Bladder Cancer Treatment Drugs Market, by Type

    • 12.2 Southwest China Bladder Cancer Treatment Drugs Market, by Application

    Chapter 13 Northwest China Bladder Cancer Treatment Drugs Market Analysis

    • 13.1 Northwest China Bladder Cancer Treatment Drugs Market, by Type

    • 13.2 Northwest China Bladder Cancer Treatment Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis International

        • 14.1.1 Novartis International Company Profile

        • 14.1.2 Novartis International Bladder Cancer Treatment Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bristol-Myers Squibb

        • 14.2.1 Bristol-Myers Squibb Company Profile

        • 14.2.2 Bristol-Myers Squibb Bladder Cancer Treatment Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sanofi

        • 14.3.1 Sanofi Company Profile

        • 14.3.2 Sanofi Bladder Cancer Treatment Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Celgene Corporation

        • 14.4.1 Celgene Corporation Company Profile

        • 14.4.2 Celgene Corporation Bladder Cancer Treatment Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Eli Lilly

        • 14.5.1 Eli Lilly Company Profile

        • 14.5.2 Eli Lilly Bladder Cancer Treatment Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Hoffmann-La Roche

        • 14.6.1 Hoffmann-La Roche Company Profile

        • 14.6.2 Hoffmann-La Roche Bladder Cancer Treatment Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 GlaxoSmithKline

        • 14.7.1 GlaxoSmithKline Company Profile

        • 14.7.2 GlaxoSmithKline Bladder Cancer Treatment Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca

        • 14.8.1 AstraZeneca Company Profile

        • 14.8.2 AstraZeneca Bladder Cancer Treatment Drugs Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bladder Cancer Treatment Drugs Industry Research Conclusions

    • 15.2 Bladder Cancer Treatment Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bladder Cancer Treatment Drugs Industry Market Size (2018-2029)

    • Figure China Bladder Cancer Treatment Drugs Production Volume, Production Value and Growth Rate of Non-Muscle-Invasive Bladder Cancer (2018-2029)

    • Figure China Bladder Cancer Treatment Drugs Production Volume, Production Value and Growth Rate of Muscle-Invasive Bladder Cancer (2018-2029)

    • Figure China Bladder Cancer Treatment Drugs Sales Volume, Sales Value and Growth Rate of High-Grade Tumors (2018-2029)

    • Figure China Bladder Cancer Treatment Drugs Sales Volume, Sales Value and Growth Rate of Low-Grade Tumors (2018-2029)

    • Figure North China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bladder Cancer Treatment Drugs Market Size and Growth Rate from 2018-2029

    • Figure Bladder Cancer Treatment Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bladder Cancer Treatment Drugs Market Share by Type in 2018

    • Figure China Bladder Cancer Treatment Drugs Market Share by Type in 2023

    • Figure China Bladder Cancer Treatment Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Production Volume and Growth Rate of Non-Muscle-Invasive Bladder Cancer (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Production Volume and Growth Rate of Muscle-Invasive Bladder Cancer (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Market Share by Application in 2018

    • Figure China Bladder Cancer Treatment Drugs Market Share by Application in 2023

    • Figure China Bladder Cancer Treatment Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Bladder Cancer Treatment Drugs Market Size and Growth Rate of High-Grade Tumors (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Market Size and Growth Rate of Low-Grade Tumors (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Production Volume by Region (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Production Volume Share by Region (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Production Volume Share by Region (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Production Value by Region (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Production Value Share by Region (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Production Value Share by Region (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Sales Volume by Region (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Sales Volume Share by Region (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Sales Value by Region (2018-2023)

    • Table China Bladder Cancer Treatment Drugs Sales Value Share by Region (2018-2023)

    • Figure China Bladder Cancer Treatment Drugs Sales Value Share by Region (2018-2023)

    • Table North China Bladder Cancer Treatment Drugs Production Volume by Type (2018-2023)

    • Table North China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Table North China Bladder Cancer Treatment Drugs Sales Volume by Application (2018-2023)

    • Table North China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Bladder Cancer Treatment Drugs Production Volume by Type (2018-2023)

    • Table Central China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Bladder Cancer Treatment Drugs Sales Volume by Application (2018-2023)

    • Table Central China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Bladder Cancer Treatment Drugs Production Volume by Type (2018-2023)

    • Table South China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Table South China Bladder Cancer Treatment Drugs Sales Volume by Application (2018-2023)

    • Table South China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Bladder Cancer Treatment Drugs Production Volume by Type (2018-2023)

    • Table East China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Table East China Bladder Cancer Treatment Drugs Sales Volume by Application (2018-2023)

    • Table East China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bladder Cancer Treatment Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Bladder Cancer Treatment Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bladder Cancer Treatment Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Bladder Cancer Treatment Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bladder Cancer Treatment Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bladder Cancer Treatment Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Bladder Cancer Treatment Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bladder Cancer Treatment Drugs Sales Volume Share by Application (2018-2023)

    • Table Novartis International Company Profile

    • Table Novartis International Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)

    • Table Hoffmann-La Roche Company Profile

    • Table Hoffmann-La Roche Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Bladder Cancer Treatment Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US